Skip to main navigation

Scientists Patients Medical Professionals Investors and Media Careers

News
Events
Stock
Financials
Governance
FAQs

Scientists
Patients
Medical Professionals
Investors and Media
Careers

INVESTORS & MEDIA

Media Statements

Press Releases

Media Statements

Year

Statement on Department of Justice Filing Related to EYLEA® (aflibercept) Injection 2 mg 89.6 KB

Share This Page

Terms of Use
Contact Us
Site Map
Social Media Terms of Engagement
Privacy Notice
Accessibility Statement

Investors and Media
Careers
Ireland
Covid-19 Antibody Program

Copyright © 2024 Regeneron Pharmaceuticals Inc. All rights reserved. All trademarks mentioned are the property of their respective owners.

Investors & Media

Search

Facebook
LinkedIn
Twitter
RSS Feeds

You are now leaving Regeneron.com. The site you are about to visit is maintained by a third party who is solely responsible for its content. We encourage you to read the privacy policy of every website you visit.

Continue

You are now leaving Regeneron.com to visit another Regeneron pharmaceuticals website.

Continue